Novo Nordisk said it expects the European Medicines Agency to implement the EU label update on Wegovy to reflect reduced heart failure symptoms and improved physical function shortly. The company also ...

The company noted that Wegovy is the first obesity medication to receive a positive opinion recommending a label update that reflects reduced symptoms and improved physical limitations and exercise ...

An extensive look at wastewater samples taken across the United States from May to July found traces of the H5N1 bird flu ...

The European Medicines Agency backed the use of Novo Nordisk's Wegovy in patients with an obesity-related heart condition, ...

Whether positive or negative, your mood may feel different on GLP-1 medications. Researchers share why that might be and how ...

With its line-up of sweet snacks, Hershey isn’t known as a purveyor of diet foods. However, the company’s newest products are ...

U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular ...

There are discrepancies between preferred and actual sources of contraceptive information for U.S. adolescents and young ...

Eli Lilly and Company ’s LLY stock has risen 21.1% in six months compared with an increase of 10.5% for the industry. The ...

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

As Eli Lilly and Novo Nordisk continue to dominate the lucrative weight-loss drug market, smaller competitors are gearing up ...

Ozempic is patented to treat type 2 diabetes, improving blood sugar to reduce the risk of major cardiovascular incidents. The ...